# Owlstone Medical

UK-based Owlstone Medical's Breath Biopsy platform acts as the global gold standard for clinical research.

Source: https://en.bioecon.ru/companies/owlstone-medical/
Updated: 2026-07-02

- Country: United Kingdom

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $169.01M total raised; latest round $27M Series E (Jan 2025) | https://www.owlstonemedical.com/about/news/2025/jan/15/press-release-series-e-financing-round/ |
| Production site | Commercial-scale Breath Biopsy Laboratory in Cambridge, UK | https://www.cambridgenetwork.co.uk/directories/companies/570, https://www.drugdiscoverynews.com/organization/owlstone-medical, https://www.owlstonemedical.com/about/news/2024/sep/30/owlstone-fda-research-collaboration-agreement-vocatlas/, https://www.owlstonemedical.com/about/news/2025/jan/15/press-release-series-e-financing-round/, https://www.owlstonemedical.com/investors/ |
| Certification | ISO 13485 certified facility | https://3formdesign.com/articles/case-study/owlstone-medical-omed/ |
| Regulatory approval | OMED Health Breath Analyzer registered as a Class 1 medical device with the FDA | https://api.ai-analytics.org/medical-device-mfr/3014845771, https://www.owlstonemedical.com/investor-relations-newsletter-august-2024/ |
| Headcount | Over 150 employees (as of Dec 2024); 123 employees (as of Oct 2026 reporting) | https://www.owlstonemedical.com/about/meet-team/ |

Independent sources: 3formdesign.com, api.ai-analytics.org, cambridgenetwork.co.uk, drugdiscoverynews.com

## Technologies

- [Breathomics](https://en.bioecon.ru/technology/breathomics/)
- [Synthetic biomarkers](https://en.bioecon.ru/technology/synthetic-biomarkers/)